Benitec Biopharma Limited Sponsored ADR

( )
BNTC After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Biotechnology
BIIBBiogen Inc.
AMGNAmgen Inc.
CELGCelgene Corporation
GILDGilead Sciences, Inc.
VRTXVertex Pharmaceuticals Incorporated
REGNRegeneron Pharmaceuticals, Inc.
ILMNIllumina, Inc.
BLUEBluebird Bio, Inc.
SRPTSarepta Therapeutics, Inc.
ALXNAlexion Pharmaceuticals, Inc.
NKTRNektar Therapeutics
EXASExact Sciences Corporation
EXELExelixis, Inc.
BMRNBioMarin Pharmaceutical Inc.
AAgilent Technologies, Inc.

Company Profile

Benitec Biopharma Ltd. engages in the development of therapeutics based on patented gene silencing technology called ddRNAi. It develops treatments for chronic and life threatening human conditions, such as oculopharyngeal muscular dystrophy, oncology, wet age-related macular degeneration, and hepatitis B. It operates through the Australia and USA geographical segments. The company was founded by Kenneth C. Reed in 1997 and is headquartered in North Sydney, Australia.